Australian researchers recently created a lot of interest in Ivermectin as they found it could zap COVID-19 in vitro. At least some French doctors have come out in support of more testing of the anti-parasitic drug, which they believe could be more effective against COVID-19 than chloroquine. Medincell's work is funded by a $6.4 M grant from Unitaid. They have now launched a clinical trial to investigate if it can work on COVID-19 in humans. The momentum gains to generate meaningful clinical data.
TrialSite News received great interest after it published a story about Australian researchers’ findings in regards to ivermectin. The topic generated thousands of reads and hundreds of messages to the Salt Lake City, Utah-based clinical trials-focused media and social network venture. Monash University’s Biomedicine Discovery Institute and Peter Doherty Institute of Infection and Immunity at Royal Melbourne Hospital published the results of a study revealing that the drug, an approved anti-parasitic available worldwide, may actually treat against SARS-CoV-2—at least when applied to an infected cell culture in a laboratory. The results were very promising as th...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).